Looking Beyond Your Ketamine Treatments?
Explore an FDA-Approved treatment option for treatment-resistant depression
that may be covered by your insurance
Explore an evidence-based alternative to ketamine
FDA-Approved Treatment
Comprehensive Psychiatric Care
Covered by Most Insurances
Spravato® nasal esketamine is FDA-approved for adults with treatment-resistant depression and certain cases of major depressive disorder with acute suicidal thoughts or behavior, when used with an oral antidepressant.
Covered by Most Insurances
Comprehensive Psychiatric Care
Covered by Most Insurances
Unlike ketamine for depression, which is typically an off-label treatment, many insurance plans provide coverage for eligible patients receiving Spravato® nasal esketamine. Our team makes verifying benefits and navigating the authorization process easy and efficient.
Needle-Free Administration
Comprehensive Psychiatric Care
Comprehensive Psychiatric Care
Spravato® nasal esketamine is administered as a nasal spray under medical supervision, eliminating the need for IV infusions while maintaining the required monitoring for safety.
Comprehensive Psychiatric Care
Comprehensive Psychiatric Care
Comprehensive Psychiatric Care
Treatment is more than receiving medication. Our clinicians evaluate your progress, monitor symptoms, adjust your treatment plan, and coordinate ongoing depression care.
Is Spravato® Nasal Esketamine the Right Next Step for You?
No pressure just expert guidance
and personalized care.